Efficacy of DPP-4 inhibitors, GLP-1 analogues, and SGLT2 inhibitors as add-ons to metformin monotherapy in T2DM patients: a model-based meta-analysis.
Hiroyuki InoueYoko TamakiYushi KashiharaShota MurakiMakoto KakaraTakeshi HirotaHiroshi ArakiPublished in: British journal of clinical pharmacology (2018)
Once weekly exenatide, liraglutide and dulaglutide provided better hypoglycaemic effects among the antidiabetic drugs analysed. Long-acting GLP-1r appears to be more useful for T2DM patients inadequately controlled with metformin monotherapy.